SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-12-009797
Filing Date
2012-02-14
Accepted
2012-02-14 16:57:16
Documents
1
Group Members
DESJARDINS-INNOVATECH S.E.C.

Document Format Files

Seq Description Document Type Size
1 SC 13G a12-5086_2sc13g.htm SC 13G 84830
  Complete submission text file 0001104659-12-009797.txt   86431
Mailing Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703
Business Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703 919 474 0020
TRANZYME INC (Subject) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86177 | Film No.: 12612039
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2 COMPLEXE DESJARDINS, #1717 P.O. BOX 760 MONTREAL A8 H5B 1B8
Business Address 2 COMPLEXE DESJARDINS, #1717 P.O. BOX 760 MONTREAL A8 H5B 1B8 15142817131
Capital regional et cooperatif Desjardins (Filed by) CIK: 0001516038 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC 13G